P305+P351+P338：IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.
Description
Lazertinib is used in the preparation of heteroaryl pyrimidinylamine compounds for modulating EGFR mutant kinase activities. EGFR tyrosine-kinase inhibitor.
